This article reviews the clinical experience of topical tacrolimus in the treatment of AD and other skin conditions.

We review newly-approved and emerging topical and systemic medications for AD as well as novel early life approaches to preventing the disease onset.

Atopic dermatitis (AD) is one of a family of inflammatory skin diseases (psoriasis, irritant contact dermatitis, and allergic contact dermatitis).

It is important to consider strategies to reduce barriers to cost-effective accessible AD education and treatment.